Metraipolis › archive › dc_c15c9928ecfc

The MRGPRX2 paradigm shift: Redefining mast cell activation pathways in chronic urticaria — Europe PMC PMID:42058742

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42058742
DOI
10.5414/alx02618e
License (as archived)
solo-consultazione
Archived
2026-11-03T06:47:30.017Z
SHA-256 of the archived text
590b6b16c238338906637af713c7e97f8ad12aef279051ebd94fd13f4610dfdf
Stable URL of this page
https://metraipolis.com/documento/dc_c15c9928ecfc

How to cite

The MRGPRX2 paradigm shift: Redefining mast cell activation pathways in chronic urticaria — Europe PMC PMID:42058742 — Europe PMC (en), https://europepmc.org/article/MED/42058742 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c15c9928ecfc (Metraipolis archive dc_c15c9928ecfc, sha256 590b6b16c238338906637af713c7e97f8ad12aef279051ebd94fd13f4610dfdf)
BibTeX
@misc{dcc15c9928ecfc,
  title = {The MRGPRX2 paradigm shift: Redefining mast cell activation pathways in chronic urticaria — Europe PMC PMID:42058742},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42058742},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c15c9928ecfc; sha256 590b6b16c238338906637af713c7e97f8ad12aef279051ebd94fd13f4610dfdf},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42058742. Agents can read the archived copy with the MCP tool read_document.